SKI Market

A+| A| A-|

Indian Indices

Sensex

73,319.55 185.23
( 0.25%)

Global Indices

Nasdaq

46,577.55 215.03
(0.46%)

Dow Jones

6,594.89 45.37
(0.69%)

Hang Seng

52,384.74 -1,354.94
(-2.52%)

Nikkei 225

10,436.29 71.50
(0.69%)

Forex

USD-INR

93.85 -0.46
(-0.49%)

EUR-INR

107.97 -0.33
(-0.30%)

GBP-INR

124.03 -0.65
(-0.52%)

JPY-INR

0.59 0.00
(-0.26%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

99.2482659

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

95.02

414713.05

EPS(TTM)

Face Value()

Div & Yield %

18.19

0.93

Back

Nilkamal consolidated net profit rises 3.20% in the September 2025 quarter

Nov 06,2025

Net profit of Nilkamal rose 3.20% to Rs 33.57 crore in the quarter ended September 2025 as against Rs 32.53 crore during the previous quarter ended September 2024. Sales rose 17.76% to Rs 967.71 crore in the quarter ended September 2025 as against Rs 821.76 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	967.71	821.76	18
OPM %	8.81	9.42	-
PBDT	79.83	72.51	10
PBT	45.06	42.83	5
NP	33.57	32.53	3

73,319.55 185.23 ( 0.25%)

46,577.55 215.03 (0.46%)

6,594.89 45.37 (0.69%)

52,384.74 -1,354.94 (-2.52%)

10,436.29 71.50 (0.69%)

93.85 -0.46 (-0.49%)

107.97 -0.33 (-0.30%)

124.03 -0.65 (-0.52%)

0.59 0.00 (-0.26%)